Bill Snyder
-
Vanderbilt’s science high begins 5th year
The first graduating class of the School for Science and Math celebrates last spring. Photo by Tommy Lawson Their research papers are published in a scientific journal. They win accolades in a prestigious national science competition. And that’s before they graduate from their public high schools. These are the… Read MoreJan 4, 2012
-
Landmark HIV prevention study Breakthrough of the Year
A landmark study that found early antiretroviral therapy (ART) can reduce the risk of HIV transmission between sexual partners by 96 percent has been named Breakthrough of the Year by Science magazine. The study, conducted by the… Read MoreDec 22, 2011
-
Record number of VU faculty elected to AAAS
Fourteen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. This is the largest number of Vanderbilt fellows to be elected in a single year on record. They are among 539 fellows from around the… Read MoreDec 22, 2011
-
New schizophrenia drug candidates entering prep for first-in-human testing
The progression of new drug candidates for schizophrenia with partner Janssen Pharmaceutica is the latest evidence that a new collaborative model for drug discovery pioneered at Vanderbilt may help identify and develop innovative candidate drugs for treatment of major brain disorders. Read MoreDec 15, 2011
-
Stanley Cohen’s Nobel Prize: 25 years of progress
Twenty-five years after he received the Nobel Prize, Stanley Cohen’s discovery of epidermal growth factor continues to transform medicine. Read MoreDec 9, 2011
-
Project seeks to apply gene testing to drug prescribing
The U.S. Centers for Disease Control and Prevention has awarded Vanderbilt researchers a two-year, $1 million grant to Vanderbilt to develop a model for applying genomic testing to drug prescribing in “real-world” settings. Read MoreNov 11, 2011
-
Microscopy method brings ‘nano-world’ into focus
A new technique for imaging whole cells in liquid – with a nanometer resolution that brings into focus individual proteins and other intracellular structures – could dramatically improve the study of cancer, viral infections and brain function. Read MoreOct 25, 2011
-
Initiative to help ‘translate’ diabetes research advances
The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home. Read MoreOct 21, 2011
-
Predicting hospital readmission is risky business: study
Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers. Read MoreOct 18, 2011
-
Discoveries show value of federal support
An update on federally funded projects at Vanderbilt and their impact on efforts to improve education, protect people from disease and meet our nation’s energy needs. Read MoreOct 13, 2011
-
Researchers strive to refill drug discovery ‘pipeline’
Researchers at Vanderbilt University Medical Center have made substantial progress in developing potential new treatments for Parkinson’s disease, schizophrenia and fragile X syndrome, the most common genetic form of autism. Read MoreOct 3, 2011
-
Drug-like molecules aimed at improving treatment of Parkinson’s
Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects. Read MoreSep 30, 2011
-
New drug-like molecules could improve schizophrenia treatment
The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia. Read MoreSep 22, 2011
-
Milestone in development of new treatment for ‘fragile X’
Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism. Read MoreSep 15, 2011
-
Picture the intangible: the intersection of art and science
Scanning electron micrograph of a Hydractinia symbiolongicarpus colony by Perrin Ireland. Art and science are not mutually exclusive. On the contrary, these two important fields of human endeavor often draw from and inspire each other. Think Leonardo da Vinci and Benjamin Franklin. A 21st century version of this cross-fertilization currently… Read MoreAug 31, 2011
-
New journal publishes budding scientists’ research
In addition to her high school diploma, Aziza Hart earned an unusual honor this spring – her first scientific paper was published in a new Vanderbilt University journal, Young Scientist. Hart, who graduated from Nashville’s Glencliff High School, spent part of her senior year in a Vanderbilt laboratory, studying… Read MoreAug 30, 2011
-
Grant bolsters liver tumor surgery techniques
A team led by Vanderbilt University biomedical engineer Michael Miga has been awarded a five-year, $3.1 million grant from the National Cancer Institute to enhance image-guided surgery techniques for safely removing liver tumors. Read MoreAug 30, 2011
-
Discovery of how G proteins ‘turn on’ may lead to better drugs
Researchers have discovered how key proteins are “turned on” and transmit signals inside the cell. The discovery could lead to new, more effective drugs. Read MoreAug 18, 2011
-
Cancer study seeks clues to halting metastasis’ march
Vanderbilt researchers have identified small molecules that can restore normal protein expression in human colorectal carcinoma cells and prevent invasive cancer growth. Read MoreAug 10, 2011
-
Real science in X-Men
First appearance from "Uncanny X-Men" #96. Art by Dave Cockrum. Via Wikipedia. Here’s another reason to love the X-Men: real science. Listen carefully to the dialogue between Professor Charles Xavier and CIA agent Dr. Moira MacTaggart in the new movie, “X-Men: First Class,” and you’ll hear a… Read MoreJun 21, 2011